Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 716
Countries 135
Faculty 405
Health Topics 136

Filter from the selections below

Clear All Filters

A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection (HVTN 703/HPTN 081)

This phase 2b trial will provide a test of concept for antibody-mediated prevention (AMP) for HIV.  HVTN 703/HPTN 081 is the first study to evaluate whether broadly neutralizing monoclonal antibodies are effective in reducing acquisition of HIV-1 infection among at-risk populations. Funding is provided by HIV Vaccine Trials Network.

Countries 
Active Dates 
07/01/2016 to 07/31/2021
Faculty Involved 
Organizations